AI assistant
CONMED Corp — Director's Dealing 2014
Oct 1, 2014
31971_dirs_2014-10-01_1eca5f6a-07f2-40dc-bb32-6548bc0c9191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-09-30
Reporting Person: ABRAHAM WILLIAM (EVP-Business Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-09-30 | Common Stock | M | 400 | — | Acquired | 1886 | Direct |
| 2014-09-30 | Common Stock | F | 145 | $36.84 | Disposed | 1741 | Direct |
| 2014-09-30 | Common Stock | M | 800 | — | Acquired | 2541 | Direct |
| 2014-09-30 | Common Stock | F | 289 | $36.84 | Disposed | 2252 | Direct |
| 2014-09-30 | Common Stock | M | 1200 | — | Acquired | 3452 | Direct |
| 2014-09-30 | Common Stock | F | 433 | $36.84 | Disposed | 3019 | Direct |
| 2014-09-30 | Common Stock | M | 1600 | — | Acquired | 4619 | Direct |
| 2014-09-30 | Common Stock | F | 578 | $36.84 | Disposed | 4041 | Direct |
| 2014-09-30 | Common Stock | M | 1300 | — | Acquired | 5341 | Direct |
| 2014-09-30 | Common Stock | F | 469 | $36.84 | Disposed | 4872 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-30 | Rsus (restricted Stock Units) | $0 | M | 400 | Disposed | 2020-06-01 | Common Stock (400) | Direct |
| 2014-09-30 | Rsus (restricted Stock Units) | $0 | M | 800 | Disposed | 2021-06-01 | Common Stock (800) | Direct |
| 2014-09-30 | Rsus (restricted Stock Units) | $0 | M | 1200 | Disposed | 2022-06-01 | Common Stock (1200) | Direct |
| 2014-09-30 | Rsus (restricted Stock Units) | $0 | M | 1600 | Disposed | 2023-06-01 | Common Stock (1600) | Direct |
| 2014-09-30 | Rsus (restricted Stock Units) | $0 | M | 1300 | Disposed | 2024-06-01 | Common Stock (1300) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F2: Upon Mr. Abraham's retirement, and upon the consent of the Compensation Committee, all unvested SARs and RSUs accelerated and vested, as permitted by the equity award terms and as contemplated by the disclosures in the Company's Form 8-K dated July 23, 2014.